Comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancer (Q26859166)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700801%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

Comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancer (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700801%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700801%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Aedin C Culhane

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700801%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Markus Riester

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700801%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

author name string

Levi Waldron

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700801%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Jie Ding

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700801%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Xin Victoria Wang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700801%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Mahnaz Ahmadifar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700801%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Svitlana Tyekucheva

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700801%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Christoph Bernau

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700801%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Thomas Risch

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700801%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Benjamin Frederick Ganzfried

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700801%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Curtis Huttenhower

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700801%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Michael Birrer

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700801%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Giovanni Parmigiani

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700801%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

language of work or name

1 reference

3 April 2014

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700801%20AND%20SRC:MED&resulttype=core&format=json

Journal of the National Cancer Institute

12 March 2020

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700801%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

volume

106

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700801%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

issue

5

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700801%20AND%20SRC:MED&resulttype=core&format=json

Why Your New Cancer Biomarker May Never Work: Recurrent Patterns and Remarkable Diversity in Biomarker Failures

12 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Scientific research in the age of omics: the good, the bad, and the sloppy

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Public availability of published research data in high-impact journals

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Bioconductor: open software development for computational biology and bioinformatics

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

21 March 2017

Cancer statistics, 2012

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Integrated genomic analyses of ovarian carcinoma

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Repeatability of published microarray gene expression analyses

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Adjusting batch effects in microarray expression data using empirical Bayes methods

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Tackling the widespread and critical impact of batch effects in high-throughput data

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Más-o-menos: a simple sign averaging method for discrimination in genomic data analysis

9 May 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Risk prediction for late-stage ovarian cancer by meta-analysis of 1525 patient samples.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Gleason scoring at a comprehensive cancer center: what's the difference?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

A systematic selection method for the development of cancer staging systems

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

A DNA repair pathway-focused score for prediction of outcomes in ovarian cancer treated with platinum-based chemotherapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Most random gene expression signatures are significantly associated with breast cancer outcome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

A seven-gene prognostic model for platinum-treated ovarian carcinomas

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Microarray-based gene expression studies in ovarian cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Molecular characterization of ovarian cancer by gene-expression profiling.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Ovarian cancer: markers of response

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

A prognostic gene expression index in ovarian cancer - validation across different independent data sets

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Gene expression profiling and prediction of clinical outcome in ovarian cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Genomic analysis of epithelial ovarian cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Progress in the management of gynecologic cancer: consensus summary statement

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Molecular scores to predict ovarian cancer outcomes: a worthy goal, but not ready for prime time

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

Genes with bimodal expression are robust diagnostic targets that define distinct subtypes of epithelial ovarian cancer with different overall survival.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4580554

A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer

28 November 2018

1 reference

12 December 2020

Retraction. An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer

1 reference

12 December 2020

Run batch effects potentially compromise the usefulness of genomic signatures for ovarian cancer

1 reference

12 December 2020

Tightening the clinical trial

1 reference

12 December 2020

inSilicoDb: an R/Bioconductor package for accessing human Affymetrix expert-curated datasets from GEO

1 reference

12 December 2020

Deriving chemosensitivity from cell lines: Forensic bioinformatics and reproducible research in high-throughput biology

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1214/09-AOAS291

Identifiers

DOI

10.1093/JNCI/DJU049

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700801%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700801%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24700801%20AND%20SRC:MED&resulttype=core&format=json